InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
50%
T+90 mean return
-0.6%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Thepaut Eric Francis Yves, Vice-Président Exécutif et Président, Europe, Moyen-Orient, Afrique. Director active across 1 company, notably Boston Scientific CORP. Aggregated, 26 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €4.6m. Activity tracked since 5 August 2021. The latest transaction was disclosed on 10 May 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations26 total
◇
12,931 shares@ US$16.313.5% of flowCommon StockSEC:0001225208-24-005975:0
0@ €61.5841Common StockSEC:0001225208-24-004027:0
2,263 shares0Common StockSEC:0001225208-24-002580:0
2,002 shares0Common StockSEC:0001225208-24-002581:0
2,379 shares0Common StockSEC:0001225208-24-002309:0
20,000 shares0Common StockSEC:0001225208-24-001783:0
13,080 shares0Common StockSEC:0001225208-24-000111:0
◇
30,688 shares@ US$12.896.5% of flowCommon StockSEC:0001225208-23-005384:0
1,714 shares0Common StockSEC:0001225208-23-002537:0
2,262 shares0Common StockSEC:0001225208-23-002368:0
2,001 shares0Common StockSEC:0001225208-23-002382:0
1,846 shares0Common StockSEC:0001225208-23-002157:0
7,092 shares0Common StockSEC:0001225208-23-000054:0
▼
14,952 shares@ US$42.721611.1% of flowCommon StockSEC:0001225208-22-011792:0
▼
20,676 shares@ US$40.9914.9% of flowCommon StockSEC:0001225208-22-009143:0
1,833 shares0Common StockSEC:0001225208-22-003870:0
1,714 shares0Common StockSEC:0001225208-22-003090:0
2,500 shares0Common StockSEC:0001225208-22-002935:0
1,846 shares0Common StockSEC:0001225208-22-002703:0
1,846 shares0Common StockSEC:0001225208-22-002703
6,175 shares0Common StockSEC:0001225208-22-000118
6,175 shares0Common StockSEC:0001225208-22-000118:0
◇
20,000 shares@ US$13.080.0002% mcap6.3% of flowCommon StockSEC:0001225208-21-011391:0
◇
20,000 shares@ US$13.084.0% of flowCommon StockSEC:0001225208-21-011391
41,741 shares@ US$44.13660.0011% mcap43.7% of flowCommon StockSEC:0001225208-21-011304:0
25 of 26 declarations
About Thepaut Eric Francis Yves
Eric Francis Yves Thepaut is the EVP & President for Europe, Middle-East, and Africa at Boston Scientific Corp. In this role, he oversees operations in these strategic regions, contributing to the company's growth and expansion. His expertise in the medical sector is essential for leading product development and market initiatives.
